These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 34359801)

  • 21. Needle-guided ablation of locally advanced pancreatic cancer: cytoreduction or immunomodulation by in vivo vaccination?
    Geboers B; Ruarus AH; Nieuwenhuizen S; Puijk RS; Scheffer HJ; de Gruijl TD; Meijerink MR
    Chin Clin Oncol; 2019 Dec; 8(6):61. PubMed ID: 31865711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Meijerink MR; Ruarus AH; Vroomen LGPH; Puijk RS; Geboers B; Nieuwenhuizen S; van den Bemd BAT; Nielsen K; de Vries JJJ; van Lienden KP; Lissenberg-Witte BI; van den Tol MP; Scheffer HJ
    Radiology; 2021 May; 299(2):470-480. PubMed ID: 33724066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison.
    van Veldhuisen E; Vroomen LG; Ruarus AH; Derksen TC; Busch OR; de Jong MC; Kazemier G; Puijk RS; Sorgedrager NS; Vogel JA; Scheffer HJ; van Lienden KP; Wilmink JW; Besselink MG; Meijerink MR
    J Vasc Interv Radiol; 2020 Oct; 31(10):1600-1608. PubMed ID: 32861569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient Derived Xenografts Expand Human Primary Pancreatic Tumor Tissue Availability for
    Brock RM; Beitel-White N; Coutermarsh-Ott S; Grider DJ; Lorenzo MF; Ringel-Scaia VM; Manuchehrabadi N; Martin RCG; Davalos RV; Allen IC
    Front Oncol; 2020; 10():843. PubMed ID: 32528898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer.
    Zhao J; Wen X; Tian L; Li T; Xu C; Wen X; Melancon MP; Gupta S; Shen B; Peng W; Li C
    Nat Commun; 2019 Feb; 10(1):899. PubMed ID: 30796212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
    Narayanan G; Hosein PJ; Beulaygue IC; Froud T; Scheffer HJ; Venkat SR; Echenique AM; Hevert EC; Livingstone AS; Rocha-Lima CM; Merchan JR; Levi JU; Yrizarry JM; Lencioni R
    J Vasc Interv Radiol; 2017 Mar; 28(3):342-348. PubMed ID: 27993507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma.
    Narayanan G; Hosein PJ; Arora G; Barbery KJ; Froud T; Livingstone AS; Franceschi D; Rocha Lima CM; Yrizarry J
    J Vasc Interv Radiol; 2012 Dec; 23(12):1613-21. PubMed ID: 23177107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the Regulatory Immunomodulation Effect of Irreversible Electroporation (IRE) in Pancreatic Adenocarcinoma.
    Pandit H; Hong YK; Li Y; Rostas J; Pulliam Z; Li SP; Martin RCG
    Ann Surg Oncol; 2019 Mar; 26(3):800-806. PubMed ID: 30610562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation.
    Shankara Narayanan JS; Ray P; Naqvi I; White R
    J Vis Exp; 2018 Jun; (136):. PubMed ID: 29939178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial.
    Bozorgmehr F; Hommertgen A; Krisam J; Lasitschka F; Kuon J; Maenz M; Huber PE; König L; Kieser M; Debus J; Thomas M; Rieken S
    BMC Cancer; 2019 Nov; 19(1):1074. PubMed ID: 31703637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.
    Martin RC; McFarland K; Ellis S; Velanovich V
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S443-9. PubMed ID: 23128941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
    van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
    BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy.
    Månsson C; Brahmstaedt R; Nilsson A; Nygren P; Karlson BM
    Eur J Surg Oncol; 2016 Sep; 42(9):1401-6. PubMed ID: 26906114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer.
    Moris D; Machairas N; Tsilimigras DI; Prodromidou A; Ejaz A; Weiss M; Hasemaki N; Felekouras E; Pawlik TM
    Ann Surg Oncol; 2019 Jun; 26(6):1657-1668. PubMed ID: 30843163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Irreversible Electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment?
    de Liguori Carino N; O'Reilly DA; Siriwardena AK; Valle JW; Radhakrishna G; Pihlak R; McNamara MG
    Eur J Surg Oncol; 2018 Oct; 44(10):1486-1493. PubMed ID: 30146253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience.
    Lambert L; Horejs J; Krska Z; Hoskovec D; Petruzelka L; Krechler T; Kriz P; Briza J
    Neoplasma; 2016; 63(2):269-73. PubMed ID: 26774149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    Immunol Lett; 2017 Jun; 186():20-27. PubMed ID: 28392199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is irreversible electroporation safe and effective in the treatment of hepatobiliary and pancreatic cancers?
    Wu LM; Zhang LL; Chen XH; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):117-124. PubMed ID: 30655073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell activation and immune memory enhancement induced by irreversible electroporation in pancreatic cancer.
    He C; Huang X; Zhang Y; Lin X; Li S
    Clin Transl Med; 2020 Jun; 10(2):e39. PubMed ID: 32508058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
    Flak RV; Stender MT; Jensen TM; Andersen KL; Henriksen SD; Mortensen PB; Sall M; Thorlacius-Ussing O
    Scand J Gastroenterol; 2019 Feb; 54(2):252-258. PubMed ID: 30907286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.